Literature DB >> 25680416

Driver gene mutations of non-small-cell lung cancer are rare in primary carcinoids of the lung: NGS study by ion Torrent.

Gemma Armengol1, Virinder Kaur Sarhadi, Mikko Rönty, Milja Tikkanen, Aija Knuuttila, Sakari Knuutila.   

Abstract

Lung carcinoids are rare neuroendocrine tumors of the lung. Very little is known about the genetic background of these tumors. We applied Ion Torrent Ampliseq next-generation technology to study hotspot mutations of 22 lung cancer-related genes from typical and atypical lung carcinoid tumors. DNA isolated from 25 formalin-fixed, paraffin-embedded carcinoid tumors were amplified to prepare barcoded libraries covering 507 mutations included in 90 amplicons. The libraries were pooled, purified, enriched, and sequenced on ion personal genome machine. The sequences were aligned and checked for known and novel variations using Torrent Suite Software v.4.0.2. One out of 25 patients had mutations in the targeted regions sequenced. This patient had mutations in BRAF, SMAD4, PIK3CA, and KRAS. All these mutations were confirmed as somatic and are previously known mutations. In summary, mutations in genes commonly mutated in non-small-cell lung cancer are not common in lung carcinoids.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25680416     DOI: 10.1007/s00408-015-9690-1

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  15 in total

1.  Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.

Authors:  Paul T C Wan; Mathew J Garnett; S Mark Roe; Sharlene Lee; Dan Niculescu-Duvaz; Valerie M Good; C Michael Jones; Christopher J Marshall; Caroline J Springer; David Barford; Richard Marais
Journal:  Cell       Date:  2004-03-19       Impact factor: 41.582

Review 2.  Oncogenic mutations of PIK3CA in human cancers.

Authors:  Yardena Samuels; Todd Waldman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1.

Authors:  Nirupa Sachithanandan; Robin A Harle; John R Burgess
Journal:  Cancer       Date:  2005-02-01       Impact factor: 6.860

4.  Mutated ephrin receptor genes in non-small cell lung carcinoma and their occurrence with driver mutations-targeted resequencing study on formalin-fixed, paraffin-embedded tumor material of 81 patients.

Authors:  Satu Mäki-Nevala; Virinder Kaur Sarhadi; Katja Tuononen; Sonja Lagström; Pekka Ellonen; Mikko Rönty; Aino Wirtanen; Aija Knuuttila; Sakari Knuutila
Journal:  Genes Chromosomes Cancer       Date:  2013-10-07       Impact factor: 5.006

Review 5.  Pulmonary neuroendocrine/carcinoid tumors: a review article.

Authors:  Erin M Bertino; Patricia D Confer; Jorge E Colonna; Patrick Ross; Gregory A Otterson
Journal:  Cancer       Date:  2009-10-01       Impact factor: 6.860

6.  Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer.

Authors:  Luping Lin; Saurabh Asthana; Elton Chan; Sourav Bandyopadhyay; Maria M Martins; Victor Olivas; Jenny Jiacheng Yan; Luu Pham; Mingxue Michelle Wang; Gideon Bollag; David B Solit; Eric A Collisson; Charles M Rudin; Barry S Taylor; Trever G Bivona
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

Review 7.  Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.

Authors:  Dorian R A Swarts; Frans C S Ramaekers; Ernst-Jan M Speel
Journal:  Biochim Biophys Acta       Date:  2012-05-10

8.  MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoids.

Authors:  Dorian R A Swarts; Aldo Scarpa; Vincenzo Corbo; Wim Van Criekinge; Manon van Engeland; Gaia Gatti; Mieke E R Henfling; Mauro Papotti; Aurel Perren; Frans C S Ramaekers; Ernst-Jan M Speel; Marco Volante
Journal:  J Clin Endocrinol Metab       Date:  2013-11-25       Impact factor: 5.958

9.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration.

Authors:  Helga Thorvaldsdóttir; James T Robinson; Jill P Mesirov
Journal:  Brief Bioinform       Date:  2012-04-19       Impact factor: 11.622

10.  Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel.

Authors:  Aldo Scarpa; Katarzyna Sikora; Matteo Fassan; Anna Maria Rachiglio; Rocco Cappellesso; Davide Antonello; Eliana Amato; Andrea Mafficini; Matilde Lambiase; Claudia Esposito; Emilio Bria; Francesca Simonato; Maria Scardoni; Giona Turri; Marco Chilosi; Giampaolo Tortora; Ambrogio Fassina; Nicola Normanno
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

View more
  12 in total

1.  Driver Gene Mutations in Primary Carcinoids of the Lung: Who Are the Best Candidates for Genetic "Next-Generation Sequencing"?

Authors:  Filippo Lococo; Alessia Ciarrocchi
Journal:  Lung       Date:  2015-05-26       Impact factor: 2.584

2.  Clinicopathological, Oncogenic, and 18F-FDG PET/CT Features of Primary Pulmonary Carcinoid in Resection Specimens.

Authors:  Yun Chen; Yun Dong; Jingyun Shi; Long Zhao
Journal:  Contrast Media Mol Imaging       Date:  2022-06-15       Impact factor: 3.009

Review 3.  Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?

Authors:  Thomas Yang Sun; Andrew Hendifar; Sukhmani K Padda
Journal:  Curr Oncol Rep       Date:  2022-03-19       Impact factor: 5.945

4.  Targeted Exome Sequencing Outcome Variations of Colorectal Tumors within and across Two Sequencing Platforms.

Authors:  Hassan Ashktorab; Hamed Azimi; Michael L Nickerson; Sara Bass; Sudhir Varma; Hassan Brim
Journal:  Next Gener Seq Appl       Date:  2016-03-14

Review 5.  Molecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics-Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-Cancer.

Authors:  Till Plönes; Walburga Engel-Riedel; Erich Stoelben; Christina Limmroth; Oliver Schildgen; Verena Schildgen
Journal:  J Pers Med       Date:  2016-01-15

Review 6.  Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.

Authors:  Catherine W Bennett; Guy Berchem; Yeoun Jin Kim; Victoria El-Khoury
Journal:  Oncotarget       Date:  2016-10-25

7.  Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.

Authors:  Michele Simbolo; Andrea Mafficini; Katarzyna O Sikora; Matteo Fassan; Stefano Barbi; Vincenzo Corbo; Luca Mastracci; Borislav Rusev; Federica Grillo; Caterina Vicentini; Roberto Ferrara; Sara Pilotto; Federico Davini; Giuseppe Pelosi; Rita T Lawlor; Marco Chilosi; Giampaolo Tortora; Emilio Bria; Gabriella Fontanini; Marco Volante; Aldo Scarpa
Journal:  J Pathol       Date:  2016-12-29       Impact factor: 7.996

8.  MGMT promoter methylation and 1p/19q co-deletion of surgically resected pulmonary carcinoid and large-cell neuroendocrine carcinoma.

Authors:  Lei Lei; Zhiming Jiang; Gu Zhang; Qiaoyuan Cheng; Hongyang Lu
Journal:  World J Surg Oncol       Date:  2018-06-18       Impact factor: 2.754

Review 9.  Systemic treatment for lung carcinoids: from bench to bedside.

Authors:  Mariangela Torniai; Laura Scortichini; Francesca Tronconi; Corrado Rubini; Francesca Morgese; Silvia Rinaldi; Paola Mazzanti; Rossana Berardi
Journal:  Clin Transl Med       Date:  2019-07-04

10.  Clinicopathological characteristics and genetic analysis of pulmonary carcinoid tumors: A single-center retrospective cohort study and literature review.

Authors:  Xiongfei Li; Yuelong Hou; Tao Shi; Yue He; Dian Ren; Zuoqing Song; Sen Wei; Gang Chen; Jun Chen; Song Xu
Journal:  Oncol Lett       Date:  2020-01-24       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.